Exclusive news, data and analytics for financial market professionals
Learn more about
Refinitiv
Skip to main content
Reuters home
World
Business
Markets
Sustainability
Legal
Breakingviews
Technology
Investigations
More
My View
Register
Author
Raghav Mahobe
Thomson Reuters
Follow
37 results
Future of Health
category
US FDA panel backs Sanofi-AstraZeneca's preventive RSV therapy
June 8, 2023
article with gallery
Business
category
Medtronic's profit forecast hit by stronger dollar, inflation
May 25, 2023
Markets
category
Ironwood bulks up on digestive therapies with $1.15 bln VectivBio buy
May 22, 2023
Healthcare & Pharmaceuticals
category
US FDA panel backs Pfizer's maternal RSV vaccine for protecting infants
May 18, 2023
Healthcare & Pharmaceuticals
category
FDA staff supports safety data for Pfizer's RSV vaccine to protect newborns
May 16, 2023
Healthcare & Pharmaceuticals
category
US FDA approves Astellas Pharma pill for menopause hot flashes
May 12, 2023
Healthcare & Pharmaceuticals
category
WHO declares end to mpox public health emergency
May 11, 2023
article with gallery
Business
category
CVS Health to pause M&A and focus on integration
May 3, 2023
Business
category
Pfizer leans on COVID products to top estimates
May 2, 2023
Healthcare & Pharmaceuticals
category
US FDA approves Biogen's ALS drug
April 25, 2023
Business
category
Centene long-term forecast allays concerns over Medicare Advantage segment
April 25, 2023
Business
category
Elevance's upbeat profit forecast overshadowed by 2024 growth fears
April 19, 2023
World
category
WHO warns Sudan's hospitals running out of supplies, staff
April 18, 2023
article with gallery
Business
category
US FDA panel backs Innoviva's drug for multidrug-resistant bacterial infections
April 17, 2023
Healthcare & Pharmaceuticals
category
Cidara gets US FDA approval for antifungal drug
March 22, 2023
Business
category
Drug developer QurAlis raises $88 mln in Sanofi-backed funding round
March 9, 2023
Healthcare & Pharmaceuticals
category
U.S. FDA approves Reata's rare genetic disorder drug
March 1, 2023
Markets
category
Globus Medical's $3 bln deal for NuVasive to fortify spinal business spooks investors
February 9, 2023
Markets
category
CVS digs into primary care with $9.5 bln Oak Street Health deal
February 8, 2023
article with gallery
Business
category
Centene warns of hit to fast-growing Medicare Advantage business next year
February 7, 2023
1 to 20 of 37